|
Volumn 12, Issue 3, 2002, Pages 231-240
|
Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line
|
Author keywords
Cimetidine; DPPE; Histamine; Histamine receptor antagonist; Melanoma; SCID mice
|
Indexed keywords
ANTIHISTAMINIC AGENT;
CIMETIDINE;
GAMMA INTERFERON;
HISTAMINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
HISTIDINE DECARBOXYLASE;
RANITIDINE;
TAMOXIFEN DERIVATIVE;
TESMILIFENE;
ANTINEOPLASTIC AGENT;
CYTOCHROME P450;
DIPHENYL ETHER DERIVATIVE;
HISTAMINE H2 RECEPTOR;
MESSENGER RNA;
N,N DIETHYL 2 ((4 PHENYLMETHYL)PHENOXY)ETHANAMINE;
N,N-DIETHYL-2-((4-PHENYLMETHYL)PHENOXY)ETHANAMINE;
RNA;
TUMOR PROTEIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CARCINOGENESIS;
CELL INFILTRATION;
CELL PROLIFERATION;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
HISTAMINE METABOLISM;
HUMAN;
HUMAN CELL;
IMMUNE RESPONSE;
INHIBITION KINETICS;
MACROPHAGE;
MELANOMA CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
SCID MOUSE;
TUMOR GROWTH;
XENOTRANSPLANTATION;
ANIMAL;
AUTOCRINE EFFECT;
CELL CULTURE;
CELL DIVISION;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG SCREENING;
ENZYMOLOGY;
EXPERIMENTAL MELANOMA;
GENETICS;
MELANOMA;
METABOLISM;
MOUSE;
MOUSE MUTANT;
PATHOLOGY;
SECRETION;
TRANSPLANTATION;
ANIMAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AUTOCRINE COMMUNICATION;
CELL DIVISION;
CIMETIDINE;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG SYNERGISM;
HISTAMINE H2 ANTAGONISTS;
HISTIDINE DECARBOXYLASE;
HUMAN;
INTERFERON TYPE II;
MACROPHAGES;
MELANOMA;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, SCID;
NEOPLASM PROTEINS;
PHENYL ETHERS;
RECEPTORS, HISTAMINE H2;
RNA, MESSENGER;
RNA, NEOPLASM;
SUPPORT, NON-U.S. GOV'T;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
ANIMALS;
HUMANS;
|
EID: 0035999106
PISSN: 09608931
EISSN: None
Source Type: Journal
DOI: 10.1097/00008390-200206000-00006 Document Type: Article |
Times cited : (23)
|
References (42)
|